COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 125 filers reported holding COHERUS BIOSCIENCES INC in Q4 2016. The put-call ratio across all filers is 4.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $5,875,000 | -31.8% | 290,000 | -25.6% | 0.74% | -22.4% |
| Q2 2019 | $8,619,000 | +40.1% | 390,000 | -13.6% | 0.95% | +31.8% |
| Q1 2019 | $6,153,000 | +111.7% | 451,131 | +40.5% | 0.72% | +116.9% |
| Q4 2018 | $2,906,000 | -46.8% | 321,131 | -3.0% | 0.33% | -39.4% |
| Q3 2018 | $5,464,000 | +11.5% | 331,131 | -5.4% | 0.55% | +9.4% |
| Q2 2018 | $4,900,000 | +26.7% | 350,000 | 0.0% | 0.50% | +5.0% |
| Q1 2018 | $3,868,000 | +25.6% | 350,000 | 0.0% | 0.48% | +14.7% |
| Q4 2017 | $3,080,000 | +28.2% | 350,000 | +94.4% | 0.42% | +35.5% |
| Q3 2017 | $2,403,000 | -0.8% | 180,000 | +6.6% | 0.31% | -11.8% |
| Q2 2017 | $2,423,000 | +2.9% | 168,872 | +51.6% | 0.35% | -6.7% |
| Q1 2017 | $2,355,000 | -24.9% | 111,357 | 0.0% | 0.37% | -37.9% |
| Q4 2016 | $3,135,000 | -99.9% | 111,357 | -15.2% | 0.60% | +7.5% |
| Q3 2016 | $3,517,740,000 | +158428.2% | 131,357 | 0.0% | 0.56% | +41.9% |
| Q2 2016 | $2,219,000 | – | 131,357 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |